These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 30425369)

  • 1. Be open about drug failures to speed up research.
    Alteri E; Guizzaro L
    Nature; 2018 Nov; 563(7731):317-319. PubMed ID: 30425369
    [No Abstract]   [Full Text] [Related]  

  • 2. Challenges in Alzheimer's Disease Drug Discovery and Development: The Role of Modeling, Simulation, and Open Data.
    Conrado DJ; Duvvuri S; Geerts H; Burton J; Biesdorf C; Ahamadi M; Macha S; Hather G; Francisco Morales J; Podichetty J; Nicholas T; Stephenson D; Trame M; Romero K; Corrigan B;
    Clin Pharmacol Ther; 2020 Apr; 107(4):796-805. PubMed ID: 31955409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lessons Learned from Alzheimer Disease: Clinical Trials with Negative Outcomes.
    Cummings J
    Clin Transl Sci; 2018 Mar; 11(2):147-152. PubMed ID: 28767185
    [No Abstract]   [Full Text] [Related]  

  • 4. Cognitive Go/No-Go decision-making criteria in Alzheimer's disease drug development.
    Wessels AM; Edgar CJ; Nathan PJ; Siemers ER; Maruff P; Harrison J
    Drug Discov Today; 2021 May; 26(5):1330-1336. PubMed ID: 33486115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Value-Generating Exploratory Trials in Neurodegenerative Dementias.
    Friedman LG; McKeehan N; Hara Y; Cummings JL; Matthews DC; Zhu J; Mohs RC; Wang D; Hendrix SB; Quintana M; Schneider LS; Grundman M; Dickson SP; Feldman HH; Jaeger J; Finger EC; Ryan JM; Niehoff D; Dickinson SL; Markowitz JT; Owen M; Travaglia A; Fillit HM
    Neurology; 2021 May; 96(20):944-954. PubMed ID: 33674360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of Clinical Trials in Preclinical Alzheimer's Disease Drug Development Programs.
    Cummings J
    J Prev Alzheimers Dis; 2020; 7(4):288-290. PubMed ID: 32920632
    [No Abstract]   [Full Text] [Related]  

  • 7. The perils of Alzheimer's drug development.
    Schneider LS; Lahiri DK
    Curr Alzheimer Res; 2009 Feb; 6(1):77-8. PubMed ID: 19199878
    [No Abstract]   [Full Text] [Related]  

  • 8. Genentech's Alzheimer's antibody trial to study disease prevention.
    Garber K
    Nat Biotechnol; 2012 Aug; 30(8):731-2. PubMed ID: 22871696
    [No Abstract]   [Full Text] [Related]  

  • 9. New drug treatment for Alzheimer's disease: lessons for healthcare policy.
    Melzer D
    BMJ; 1998 Mar; 316(7133):762-4. PubMed ID: 9529416
    [No Abstract]   [Full Text] [Related]  

  • 10. Expose your clinical thinking.
    Nat Biotechnol; 2004 Aug; 22(8):927. PubMed ID: 15286628
    [No Abstract]   [Full Text] [Related]  

  • 11. Sting of Alzheimer's failures offset by upcoming prevention trials.
    Mullard A
    Nat Rev Drug Discov; 2012 Sep; 11(9):657-60. PubMed ID: 22935790
    [No Abstract]   [Full Text] [Related]  

  • 12. Targeting apolipoprotein E for treating Alzheimer's disease.
    Bales KR; Paul SM
    Neurosci Lett; 2019 Sep; 709():134366. PubMed ID: 31336138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The coronavirus outbreak could make it quicker and easier to trial drugs.
    Ledford H
    Nature; 2020 Jun; 582(7811):172. PubMed ID: 32504019
    [No Abstract]   [Full Text] [Related]  

  • 14. Commentary: Why we should report results from clinical trial pilot studies.
    Friedman L
    Trials; 2013 Jan; 14():14. PubMed ID: 23305191
    [No Abstract]   [Full Text] [Related]  

  • 15. Alzheimer's disease research: the future of BACE inhibitors.
    Burki T
    Lancet; 2018 Jun; 391(10139):2486. PubMed ID: 29976459
    [No Abstract]   [Full Text] [Related]  

  • 16. New Approaches to Develop Drug Treatment for Alzheimer's Disease: Targeting Calcium Dysregulation.
    Wei H
    Curr Alzheimer Res; 2020; 17(4):311-312. PubMed ID: 32623998
    [No Abstract]   [Full Text] [Related]  

  • 17. Sharing Historical Trial Data to Accelerate Clinical Development.
    Yin PT; Desmond J; Day J
    Clin Pharmacol Ther; 2019 Dec; 106(6):1177-1178. PubMed ID: 31538661
    [No Abstract]   [Full Text] [Related]  

  • 18. Translational Scoring of Candidate Treatments for Alzheimer's Disease: A Systematic Approach.
    Cummings JL
    Dement Geriatr Cogn Disord; 2020; 49(1):22-37. PubMed ID: 32512572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alzheimer's disease: future drug development and the blood-brain barrier.
    Pardridge WM
    Expert Opin Investig Drugs; 2019 Jul; 28(7):569-572. PubMed ID: 31155971
    [No Abstract]   [Full Text] [Related]  

  • 20. New drug treatment for Alzheimer's disease. Information from unpublished trials should be made available.
    Johnstone P
    BMJ; 1998 Oct; 317(7163):946. PubMed ID: 9841010
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.